Hotspot residues and resistance mutations in the nirmatrelvir-binding site of SARS-CoV-2 main protease: Design, identification, and correlation with globally circulating viral genomes-Reference-Cited by-同舟云学术

Hotspot residues and resistance mutations in the nirmatrelvir-binding site of SARS-CoV-2 main protease: Design, identification, and correlation with globally circulating viral genomes

Published:2022-11 Issue: Volume:629 Page:54-60
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Padhi Aditya K.^ORCID,Tripathi Timir^ORCID

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference27 articles.

1. SARS-CoV-2 variants, spike mutations and immune escape;Harvey;Nat. Rev. Microbiol.,2021

2. Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity;Garcia-Beltran;Cell,2021

3. Prediction and mitigation of mutation threats to COVID-19 vaccines and antibody therapies;Chen;Chem. Sci.,2021

4. Human coronaviruses: the emergence of SARS-CoV-2 and management of COVID-19;Solomon;Virus Res.,2022

5. An oral SARS-CoV-2 M(pro) inhibitor clinical candidate for the treatment of COVID-19;Owen;Science,2021

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive study of SARS-CoV-2 mfigain protease (Mpro) inhibitor-resistant mutants selected in a VSV-based system;PLOS Pathogens;2024-09-11

2. Variant-proof high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways;Nature Communications;2024-08-12

3. Computational Insights into SARS-CoV-2 Main Protease Mutations and Nirmatrelvir Efficacy: The Effects of P132H and P132H-A173V;Journal of Chemical Information and Modeling;2024-06-24

4. Increasing the efficiency of gene editing with CRISPR-Cas9 via concurrent expression of the Beta protein;International Journal of Biological Macromolecules;2024-06

5. A Cell-Based Papain-like Protease (PLpro) Activity Assay for Rapid Detection of Active SARS-CoV-2 Infections and Antivirals;2024-05-21